Marksans Pharma Limited
NSE:MARKSANS.NS
Overview | Financials
Company Name | Marksans Pharma Limited |
Symbol | MARKSANS.NS |
Currency | INR |
Price | 299.4 |
Market Cap | 135,677,301,600 |
Dividend Yield | 0.3% |
52-week-range | 125 - 328.8 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Mark B. Saldanha |
Website | https://marksanspharma.com |
An error occurred while fetching data.
About Marksans Pharma Limited
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD